Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axcella Health Inc. - Common Stock (NQ:AXLA)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axcella Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Axcella Therapeutics Puts Development Of NASH Program Aside, Reduces Workforce By 85%
 
Via Benzinga
Recap: Axcella Health Q3 Earnings
Axcella Health (NASDAQ:AXLA) reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Axcella Shares Jump Despite Mixed Bag Data From Mid-Stage NASH Trial
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
 
Via Benzinga
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. 
Via Benzinga
Axcella Health: Q2 Earnings Insights
  Axcella Health (NASDAQ:AXLA) reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Axcella Announces Program Reprioritization and Corporate Restructuring
From Axcella Therapeutics
Via Business Wire
Axcella to Present at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting
From Axcella Therapeutics
Via Business Wire
Axcella Reports Third Quarter Financial Results and Provides Business Update
From Axcella Therapeutics
Via Business Wire
Axcella Therapeutics to Report Third Quarter 2022 Financial Results on November 1, 2022
From Axcella Therapeutics
Via Business Wire
$6 Million Bet On This This Stock? Check Out These 3 Penny Stocks Insiders Are Buying
Gold futures traded slightly lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
Axcella Therapeutics to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference
From Axcella Therapeutics
Via Business Wire
Axcella Therapeutics Announces $34.2 Million Registered Direct Offering of Common Stock Priced At The Market: Appoints Two New Board Members
From Axcella Therapeutics
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Statera BioPharma (NASDAQ:STAB) stock increased by 64.8% to $0.23 during Thursday's pre-market session. The company's market cap stands at $11.5 million. 
Via Benzinga
Looking Into Axcella Health's Recent Short Interest
Axcella Health's (NASDAQ:AXLA) short percent of float has risen 18.87% since its last report. The company recently reported that it has 113 thousand shares sold short, which is 0.63% of all regular... 
Via Benzinga
Wells Fargo To Surge Around 20%? Here Are 5 Other Price Target Changes For Monday
Goldman Sachs raised Wells Fargo & Company (NYSE: WFC) price target from $46 to $48. Goldman Sachs analyst Richard Ramsden upgraded the stock from Neutral to Buy. Wells Fargo shares rose 1.1% to $40.68... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Ainos (NASDAQ:AIMD) shares increased by 46.4% to $2.02 during Friday's pre-market session. The market value of their outstanding shares is at $39.3 million. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning! We're taking a look at the biggest pre-market stock movers traders need to know about on Thursday morning! 
Via InvestorPlace
Axcella Announces Positive Interim Data from Phase 2b EMMPACT Study of AXA1125 in Nonalcoholic Steatohepatitis (NASH)
From Axcella Therapeutics
Via Business Wire
Peering Into Axcella Health's Recent Short Interest
Axcella Health's (NASDAQ:AXLA) short percent of float has fallen 8.62% since its last report. The company recently reported that it has 96 thousand shares sold short, which is... 
Via Benzinga
Axcella Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
From Axcella Therapeutics
Via Business Wire
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday. 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
  
Via Benzinga
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74. 
Via Benzinga
Axcella Reports Second Quarter Financial Results and Provides Business Update
From Axcella Therapeutics
Via Business Wire
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday. 
Via Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.